ECM2 and cancer: Additionally, our findings suggest that the lack of HOXB2 subsequently downregulates MATN3 and the ECM2 downstream transcriptional network, leading to aggressive cancer progression, EMT-like characteristics, and poor prognosis (Fig. 8e).